Dishman Netherlands Completes Production Laboratory With Six Cleanrooms

The new high containment cGMP laboratory of Dishman Netherlands was opened formally on November 27th by Mr. Jay Vyas, Chairman and owner of the Indian Dishman Group. Important attendees included different representatives from multinationals as Pfizer and Solvay.

This project was realized with the support of several companies: Van Spanje, Techtron, Cleangrad, de Van Looy Group, Termovent and Waldner Benelux.

Dishman Netherlands has accomplished the construction and validation of a full cGMP production laboratory for APIs in Veenendaal, The Netherlands. The laboratory consists of 6 dedicated clean rooms with a scale of operation of up to 1 kg in addition to all standard laboratory facilities. FDA compliance audit is expected in H1 of 2010.

The decision to build this production laboratory is part of Dishman’s strategy to develop new Vitamin D analogues and highly potent API’s to complement the current product portfolio. Furthermore, to develop business opportunities with new business partners: for contract research, product development and contract manufacturing.

Dishman Netherlands currently offers vitamin D analogues such as alfacalcidol, calcifediol, calcitriol, & dihydrotachysterol-2. Our other products include Vitamin D3 and D2; cholesterol and lanolin alcohols. Vitamin D and vitamin D analogs are used in the food, feed and pharmaceuticals industries. Vitamin D analogues are used in the combat against Psoriasis, Osteoporosis and rickets. Cholesterol is used in diverse applications such as drug delivery systems, cosmetics, animal nutrition (shrimps) and liquid crystals. Lanolin oils are used in cosmetics (Dusoran) and also for the treatment of leather.

The opening of this laboratory in the midst of an economic recession is a sign of the strong commitment which the Dishman Group has to its Dutch subsidiary.

About Dishman Netherlands
Dishman Netherlands (www.dishman-netherlands.com) location in Veenendaal was founded in 1946. It was taken over by the Indian Dishman Group from the Belgian company Solvay pharmaceuticals in November 2007.

Dishman Group (www.dishmanGroup.com) is headquartered in Ahmedabad, India and is listed on the Bombay Stock Exchange (BSE). In 2008/09, Dishman had sales of over US$230m. Dishman Group is a global outsourcing partner for the pharmaceutical industry offering a portfolio of development, scale-up and manufacturing services.
The products and services offered span customers’ needs from chemical development to commercial manufacture and supply of active pharmaceutical ingredients.

Source : Dishman Netherlands